Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II trial of DM-199 for the treatment of chronic kidney disease

Trial Profile

Phase II trial of DM-199 for the treatment of chronic kidney disease

Planning
Phase of Trial: Phase II

Latest Information Update: 03 Jan 2019

At a glance

  • Drugs DM 199 (Primary)
  • Indications Diabetic nephropathies
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Jan 2019 According to a DiaMedica Therapeutics media release, the company expects to complete this study in in Q4 2019 or Q1 2020.
    • 03 May 2018 According to a DiaMedica Therapeutics media release, the company is preparing to file an IND as per guidance received from the FDA during a type-B meeting and expects to initiate this trial in second half of 2018.
    • 23 Jan 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top